These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 839561)

  • 21. Evidence for reduced capacity for damage accumulation and repair in plateau-phase C3H 10T1/2 cells following multiple-dose irradiation with gamma rays.
    Ngo FQ; Youngman K; Suzuki S; Koumoundouros I; Iliakis G
    Radiat Res; 1986 Jun; 106(3):380-95. PubMed ID: 3714980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ACNU, a water-soluble nitrosourea derivative, on survival and cell kinetics of cultured HeLa S3 cells.
    Kanazawa H; Miyamoto T
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1225-31. PubMed ID: 3865775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of 1,2:5,6-dianhydrogalactitol in studies on cell kinetics-directed chemotherapy schedules in human tumors in vivo.
    Barranco SC; Townsend CM; Costanzi JJ; May JT; Baltz R; O'Quinn AG; Leipzig B; Hokanson KM; Guseman LF; Boerwinkle WR
    Cancer Res; 1982 Jul; 42(7):2899-2905. PubMed ID: 7083178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival and cycle-progression delay of cultured human lymphoma cells treated with 1-propanol, 3,3'-iminodi-, dimethanesulfonate (ester), hydrochloride (Yoshi 864).
    Drewinko B; Barlogie B
    Cancer Treat Rep; 1976 Nov; 60(11):1637-45. PubMed ID: 191191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical toxicologic evaluation of dianhydrogalactitol in dogs and monkeys.
    Folk RM; Pavkov KL; Thake DC
    Cancer Treat Rep; 1976 Oct; 60(10):1585-9. PubMed ID: 828520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population.
    Leung BS; Potter AH
    J Cell Biochem; 1987 Jul; 34(3):213-25. PubMed ID: 3611201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A preliminary Pharmacokinetic study of dianhydrogalactitol (NSC-132313) disposition in the dog.
    Kimura T; Sternson LA; Stella VJ; Higuchi T
    J Natl Cancer Inst; 1977 May; 58(5):1311-4. PubMed ID: 857026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of dianhydrogalactitol and ICRF-159 in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy.
    Ahmann DL; O'Connell MJ; Bisel HF; Edmonson JH; Hahn RG; Frytak S
    Cancer Treat Rep; 1977; 61(1):81-2. PubMed ID: 324622
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of dibromo-dulcitol and dianhydro-dulcitol (galactitol) on RNA synthesis in ascites tumor cells.
    Fónagy A; Jeney A; Szamos J; Institóris L; Hidvégi EJ
    Acta Biochim Biophys Acad Sci Hung; 1981; 16(3-4):151-62. PubMed ID: 6182726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of ACNU, a water-soluble nitrosourea derivative, on survival and cell progression of cultured HeLa S3 cells].
    Kanawaza H; Miyamoto T
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2007-15. PubMed ID: 6577814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I trial of dianhydrogalactitol administered Iv in a weekly schedule.
    Vogel CL; Winton EF; Moore MR; Sohner S
    Cancer Treat Rep; 1976 Jul; 60(7):895-901. PubMed ID: 795538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,2:5,6-Dianhydrogalactitol in advanced breast cancer.
    Hoogstraten B; O'Bryan R; Jones S
    Cancer Treat Rep; 1978 May; 62(5):841-2. PubMed ID: 657167
    [No Abstract]   [Full Text] [Related]  

  • 33. Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Sano Y; Hoshino T; Barker M; Deen DF
    Cancer Res; 1984 Feb; 44(2):571-6. PubMed ID: 6692362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of VP-16-213 versus dianhydrogalactitol in patients with metastatic malignant melanoma.
    Ahmann DL; Bisel HF; Edmonson JH; Hahn RG; O'Connell MJ; Frytak S
    Cancer Treat Rep; 1976 Nov; 60(11):1681-2. PubMed ID: 1021239
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of cytostatic hexitol derivatives on haematopoietic stem cells, the L1210 leukaemia and C22LR osteosarcoma.
    Fuzy M; Lelieveld P; Van Putten LM
    Eur J Cancer (1965); 1975 Mar; 11(3):169-73. PubMed ID: 165939
    [No Abstract]   [Full Text] [Related]  

  • 37. Cell-cycle-dependent repair of potentially lethal damage in the XR-1 gamma-ray-sensitive Chinese hamster ovary cell.
    Stamato TD; Dipatri A; Giaccia A
    Radiat Res; 1988 Aug; 115(2):325-33. PubMed ID: 3406371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection against thermal cell death in Chinese hamster ovary cells by glucose, galactose, or mannose.
    Henle KJ; Monson TP; Moss AJ; Nagle WA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5499-504. PubMed ID: 6498812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells.
    Gorodetsky R; Levdansky L; Ringel I; Vexler A
    Radiat Res; 1998 Sep; 150(3):283-91. PubMed ID: 9728657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.
    Eagan RT; Ingle JN; Frytak S; Rubin J; Kvols LK; Carr DT; Coles DT; O'Fallon JR
    Cancer Treat Rep; 1977 Oct; 61(7):1339-45. PubMed ID: 589599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.